Live Cell Imaging Market Size 2023-2028: Share, Growth, Industry Analysis

PRESS RELEASE
Published April 25, 2023

According to the latest report by IMARC Group, titled “Live Cell Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028″, The global live cell imaging market size reached US$ 2.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.5 Billion by 2028, exhibiting a growth rate (CAGR) of 9.01% during 2023-2028. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

Industry Definition and Application:

Live cell imaging represents the procedures of examining dynamic living cells in their growth medium that change over time. They involve the usage of several equipment, consumables, and software to culture cells on the microscope stage and maintain a constant focal plane for following cellular processes in real-time. Live cell imaging solutions help to monitor cell fusion events, determine the mobility of molecules by utilizing fluorescence recovery after photobleaching or FRAP, and measure various modifications, such as the growth or aging of condensate over a period. They provide essential cellular data through the visualization of transient events that are usually missed in endpoint assays. Live cell imaging methods even aid in determining the fertilization process, cellular development, cell signaling process, and cell differentiation and facilitate accurate information on cell cultures. Consequently, they find widespread applications in numerous sectors, including pharmaceutical, biotechnology, academic research, etc.

Live Cell Imaging Market Trends and Drivers:

The growing prevalence of chronic ailments and the rising number of innovations made in medical research for developing novel drugs and therapies to treat multiple life-threatening conditions in individuals are primarily driving the live cell imaging market. Additionally, the expanding utilization of high-content screening (HCS) for making drug development processes time and cost-efficient and lower toxicity is further propelling the market growth. Moreover, the elevating focus of key market players on innovating superior live cell imaging techniques with improved features in camera technology, sensitivity, pixel density, etc., is acting as another significant growth-inducing factor. Apart from this, the inflating number of investments by government bodies across countries to improve healthcare infrastructure and promote the adoption of advanced surgical approaches to deliver effective treatment to patients are expected to fuel the live cell imaging market in the coming years.

Request Free Sample Report: https://www.imarcgroup.com/live-cell-imaging-market/requestsample

Global Live Cell Imaging Market 2023-2028 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Becton Dickinson and Company (BD)
  • Carl Zeiss AG
  • Leica Microsystems (Danaher Corporation)
  • Merck KGaA
  • Nikon Instruments Inc.
  • Olympus Corporation
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.

The report has segmented the market on the basis on region, product, application and technology.

Breakup by Product:

  • Equipment
  • Consumable
  • Software

Breakup by Application:

  • Cell Biology
  • Developmental Biology
  • Stem Cell and Drug Discovery
  • Others

Breakup by Technology:

  • Time-Lapse Microscopy
  • Fluorescence Recovery after Photobleaching (FRAP)
  • Fluorescence Resonance Energy Transfer (FRET)
  • High Content Screening (HCS)
  • Others

Breakup by Region:

  • North America:( United States, Canada)
  • Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico,Others)
  • Middle East and Africa

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023- 2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4101&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA 
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

IMARC